Zhejiang Medicine Co., Ltd. (SHA: 600216)
China
· Delayed Price · Currency is CNY
16.75
+0.11 (0.66%)
Nov 19, 2024, 3:00 PM CST
Zhejiang Medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 1,636 | 1,460 | 1,438 | 1,769 | 1,629 | 1,278 | Upgrade
|
Short-Term Investments | - | - | - | 2.9 | 50 | 151.35 | Upgrade
|
Trading Asset Securities | 328.2 | 328.31 | 447.29 | 454.4 | 270.73 | 328.63 | Upgrade
|
Cash & Short-Term Investments | 1,964 | 1,788 | 1,885 | 2,226 | 1,950 | 1,758 | Upgrade
|
Cash Growth | 14.44% | -5.15% | -15.30% | 14.17% | 10.91% | 0.12% | Upgrade
|
Accounts Receivable | 1,905 | 1,419 | 1,501 | 1,594 | 1,402 | 1,606 | Upgrade
|
Other Receivables | 134.88 | 239.14 | 67.35 | 105.17 | 141.38 | 94.05 | Upgrade
|
Receivables | 2,040 | 1,658 | 1,568 | 1,699 | 1,544 | 1,700 | Upgrade
|
Inventory | 1,945 | 2,011 | 1,995 | 1,873 | 1,480 | 1,435 | Upgrade
|
Prepaid Expenses | - | - | 0.03 | 0.36 | 0.9 | 3 | Upgrade
|
Other Current Assets | 197.51 | 143.88 | 207.17 | 236.04 | 143.85 | 143.77 | Upgrade
|
Total Current Assets | 6,147 | 5,601 | 5,655 | 6,035 | 5,118 | 5,039 | Upgrade
|
Property, Plant & Equipment | 6,183 | 6,019 | 5,618 | 5,360 | 4,513 | 4,459 | Upgrade
|
Long-Term Investments | 150.59 | 166.21 | 144.51 | 126.07 | 195.48 | 209.13 | Upgrade
|
Goodwill | 18.68 | 18.68 | 27.91 | 36.03 | - | - | Upgrade
|
Other Intangible Assets | 698.67 | 744.3 | 747.68 | 728.81 | 409.75 | 406.89 | Upgrade
|
Long-Term Deferred Tax Assets | 84.48 | 82.12 | 77.41 | 78.8 | 86.49 | 77.39 | Upgrade
|
Long-Term Deferred Charges | 12.44 | 6.22 | 8.85 | 0.41 | 27.18 | 28.26 | Upgrade
|
Other Long-Term Assets | 134.9 | 141.15 | 153.27 | 167.76 | 150.18 | 142.39 | Upgrade
|
Total Assets | 13,430 | 12,780 | 12,433 | 12,532 | 10,500 | 10,362 | Upgrade
|
Accounts Payable | 1,173 | 744.03 | 702.48 | 897.83 | 504.75 | 637.39 | Upgrade
|
Accrued Expenses | 137.63 | 253.95 | 263.98 | 287.32 | 534.42 | 433.24 | Upgrade
|
Short-Term Debt | 235.23 | 231.41 | 82.25 | 225.33 | 250.31 | 649.98 | Upgrade
|
Current Portion of Long-Term Debt | 141.66 | 370.37 | 550.64 | - | 200.17 | - | Upgrade
|
Current Portion of Leases | - | 0.3 | 0.28 | - | - | - | Upgrade
|
Current Income Taxes Payable | 211.93 | 11.88 | 21.75 | 153.51 | 95.69 | 46.41 | Upgrade
|
Current Unearned Revenue | 45.69 | 43.95 | 61.88 | 53.81 | 54.6 | 51.52 | Upgrade
|
Other Current Liabilities | 412.54 | 822.53 | 782.11 | 1,407 | 284.22 | 232.03 | Upgrade
|
Total Current Liabilities | 2,358 | 2,478 | 2,465 | 3,025 | 1,924 | 2,051 | Upgrade
|
Long-Term Debt | 372.31 | 230.22 | 200.19 | 250.34 | 500.65 | - | Upgrade
|
Long-Term Leases | 0.53 | 0.32 | 0.62 | 1.16 | - | - | Upgrade
|
Long-Term Unearned Revenue | 89.12 | 84.16 | 54.11 | 53.08 | 34.24 | 36.56 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 2.47 | 21.12 | 11.38 | 23.02 | Upgrade
|
Total Liabilities | 2,820 | 2,793 | 2,723 | 3,350 | 2,470 | 2,110 | Upgrade
|
Common Stock | 961.64 | 964.98 | 965.13 | 965.13 | 965.13 | 965.13 | Upgrade
|
Additional Paid-In Capital | 1,988 | 2,005 | 1,941 | 1,692 | 1,398 | 1,343 | Upgrade
|
Retained Earnings | 7,388 | 6,682 | 6,417 | 6,195 | 5,371 | 5,611 | Upgrade
|
Treasury Stock | - | -27.63 | -57.69 | -59.98 | -59.98 | -59.98 | Upgrade
|
Comprehensive Income & Other | 4.38 | 5.77 | -5.27 | -13.99 | 0.41 | 1.4 | Upgrade
|
Total Common Equity | 10,341 | 9,631 | 9,260 | 8,779 | 7,675 | 7,861 | Upgrade
|
Minority Interest | 268.1 | 355.68 | 449.98 | 402.93 | 355.48 | 391.39 | Upgrade
|
Shareholders' Equity | 10,609 | 9,986 | 9,710 | 9,182 | 8,030 | 8,252 | Upgrade
|
Total Liabilities & Equity | 13,430 | 12,780 | 12,433 | 12,532 | 10,500 | 10,362 | Upgrade
|
Total Debt | 749.73 | 832.63 | 833.97 | 476.82 | 951.12 | 649.98 | Upgrade
|
Net Cash (Debt) | 1,214 | 955.7 | 1,051 | 1,749 | 998.53 | 1,108 | Upgrade
|
Net Cash Growth | 32.77% | -9.10% | -39.89% | 75.16% | -9.87% | -12.12% | Upgrade
|
Net Cash Per Share | 1.27 | 0.99 | 1.09 | 1.82 | 1.04 | 1.16 | Upgrade
|
Filing Date Shares Outstanding | 961.64 | 925.92 | 958.3 | 958.3 | 958.3 | 958.3 | Upgrade
|
Total Common Shares Outstanding | 961.64 | 925.92 | 958.3 | 958.3 | 958.3 | 958.3 | Upgrade
|
Working Capital | 3,789 | 3,123 | 3,190 | 3,010 | 3,194 | 2,989 | Upgrade
|
Book Value Per Share | 10.75 | 10.40 | 9.66 | 9.16 | 8.01 | 8.20 | Upgrade
|
Tangible Book Value | 9,624 | 8,868 | 8,484 | 8,014 | 7,265 | 7,454 | Upgrade
|
Tangible Book Value Per Share | 10.01 | 9.58 | 8.85 | 8.36 | 7.58 | 7.78 | Upgrade
|
Buildings | - | 2,919 | 2,812 | 2,509 | 2,171 | 2,031 | Upgrade
|
Machinery | - | 6,897 | 6,158 | 5,366 | 4,839 | 4,692 | Upgrade
|
Construction In Progress | - | 931.69 | 825.71 | 1,119 | 638.83 | 466.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.